GeneDx Holdings (WGS) Cash from Operations Growth (1y) (2021 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 45.83% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 9.74% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -28.21% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 4.16% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -117.04% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 290.74% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 54.13% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 672.93% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 48.51% |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -378.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -378.13% |
| Mar 31, 2026 | -418.29% |
| Dec 31, 2025 | 2.92% |
| Sep 30, 2025 | 458.75% |
| Jun 30, 2025 | 331.30% |
| Mar 31, 2025 | 162.04% |
| Dec 31, 2024 | 89.34% |
| Sep 30, 2024 | 89.34% |
| Jun 30, 2024 | 91.58% |
| Mar 31, 2024 | 70.46% |
| Dec 31, 2023 | 53.82% |
| Sep 30, 2023 | 53.34% |
| Jun 30, 2023 | 36.79% |
| Mar 31, 2023 | 31.82% |
| Dec 31, 2022 | -24.37% |
| Sep 30, 2022 | -24.56% |
| Jun 30, 2022 | -234.55% |
| Mar 31, 2022 | -93.08% |
| Dec 31, 2021 | -13,363.92% |
| Sep 30, 2021 | -19,292.69% |